Zobrazeno 1 - 10
of 26
pro vyhledávání: '"de Stanchina, Elisa"'
Autor:
Cocco E; University of Miami, Miller School of Medicine, Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, Miami, Florida 33136, USA., de Stanchina E; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA destance@mskcc.org.
Publikováno v:
Cold Spring Harbor perspectives in medicine [Cold Spring Harb Perspect Med] 2024 Jul 01; Vol. 14 (7). Date of Electronic Publication: 2024 Jul 01.
Autor:
Kim D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Herdeis L; Boehringer Ingelheim, Vienna, Austria., Rudolph D; Boehringer Ingelheim, Vienna, Austria., Zhao Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Böttcher J; Boehringer Ingelheim, Vienna, Austria., Vides A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ayala-Santos CI; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pourfarjam Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cuevas-Navarro A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xue JY; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mantoulidis A; Boehringer Ingelheim, Vienna, Austria., Bröker J; Boehringer Ingelheim, Vienna, Austria., Wunberg T; Boehringer Ingelheim, Vienna, Austria., Schaaf O; Boehringer Ingelheim, Vienna, Austria., Popow J; Boehringer Ingelheim, Vienna, Austria., Wolkerstorfer B; Boehringer Ingelheim, Vienna, Austria., Kropatsch KG; Boehringer Ingelheim, Vienna, Austria., Qu R; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sang B; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McConnell DB; Boehringer Ingelheim, Vienna, Austria., Kraut N; Boehringer Ingelheim, Vienna, Austria., Lito P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. litop@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. litop@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. litop@mskcc.org.
Publikováno v:
Nature [Nature] 2023 Jul; Vol. 619 (7968), pp. 160-166. Date of Electronic Publication: 2023 May 31.
Autor:
Glasner A; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rose SA; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sharma R; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gudjonson H; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chu T; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Green JA; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rampersaud S; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Valdez IK; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Andretta ES; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dhillon BS; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schizas M; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dikiy S; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mendoza A; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hu W; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wang ZM; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chaudhary O; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xu T; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mazutis L; Institute of Biotechnology, Life Sciences Centre, Vilnius University, Vilnius, Lithuania., Rizzuto G; Human Oncology & Pathogenesis Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology & Laboratory Medicine, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Quintanal-Villalonga A; Department of Medicine, Thoracic Oncology Service, New York, NY, USA., Manoj P; Department of Medicine, Thoracic Oncology Service, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, New York, NY, USA.; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rudin CM; Department of Medicine, Thoracic Oncology Service, New York, NY, USA., Pe'er D; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. peerd@mskcc.org.; Howard Hughes Medical Institute, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. peerd@mskcc.org., Rudensky AY; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. rudenska@mskcc.org.; Howard Hughes Medical Institute, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. rudenska@mskcc.org.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Jun; Vol. 24 (6), pp. 1020-1035. Date of Electronic Publication: 2023 May 01.
Autor:
Yang Y; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA., Yang H; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Alcaina Y; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA., Puc J; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Birt A; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Vedvyas Y; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA., Gallagher M; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Alla S; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Riascos MC; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA.; Department of Surgery, Weill Cornell Medicine, New York, NY, 10065, USA., McCloskey JE; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA., Du K; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Gonzalez-Valdivieso J; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA., Min IM; Department of Surgery, Weill Cornell Medicine, New York, NY, 10065, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Britz M; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., von Hofe E; AffyImmune Therapeutics, Inc., Natick, MA, 01760, USA., Jin MM; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA. moj2005@med.cornell.edu.; Department of Surgery, Weill Cornell Medicine, New York, NY, 10065, USA. moj2005@med.cornell.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Apr 12; Vol. 14 (1), pp. 2068. Date of Electronic Publication: 2023 Apr 12.
Autor:
Li X; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065.; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10021., Huang CH; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065.; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10021., Sánchez-Rivera FJ; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Kennedy MC; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Tschaharganeh DF; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Morris JP 4th; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Montinaro A; Centre for Cell Death, Cancer, and Inflammation, UCL Cancer Institute, University College London, London WC1E 6DD, United Kingdom., O'Rourke KP; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065.; Weill Cornell Medicine/The Rockefeller University/Sloan Kettering Institute Tri-Institutional MD-PhD Program, New York, NY 10065., Banito A; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Wilkinson JE; Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109., Chen CC; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065.; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10021., Ho YJ; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Dow LE; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Tian S; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Luan W; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., de Stanchina E; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065., Zhang T; Innovative Medicines Accelerator, Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H), Stanford University, Stanford, CA 94305., Gray NS; Innovative Medicines Accelerator, Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H), Stanford University, Stanford, CA 94305., Walczak H; Centre for Cell Death, Cancer, and Inflammation, UCL Cancer Institute, University College London, London WC1E 6DD, United Kingdom.; Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cluster of Excellence, University of Cologne, Cologne 50931, Germany.; Center for Biochemistry, Medical Faculty, University of Cologne, 50931 Cologne, Germany., Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY 10065.; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10021.; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Apr 26; Vol. 119 (17), pp. e2110557119. Date of Electronic Publication: 2022 Apr 20.
Autor:
Samstein RM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Mount Sinai Hospital, New York, NY, USA.; Precision Immunology Institute at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Krishna C; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ma X; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pei X; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee KW; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Makarov V; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kuo F; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chung J; Precision Immunology Institute at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Srivastava RM; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Purohit TA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hoen DR; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mandal R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Setton J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah R; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Qeriqi B; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chang Q; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kendall S; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Braunstein L; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Blecua Carrillo Albornoz P; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Morris LGT; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mandelker DL; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Powell SN; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chan TA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chant2@ccf.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chant2@ccf.org.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chant2@ccf.org.; Center for Immunotherapy and Precision Immuno-Oncology, Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA. chant2@ccf.org., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. riazn@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. riazn@mskcc.org.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA. riazn@mskcc.org.
Publikováno v:
Nature cancer [Nat Cancer] 2021 Dec; Vol. 1 (12), pp. 1188-1203. Date of Electronic Publication: 2020 Nov 16.
Autor:
Joshi S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Gomes ED; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Wang T; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Corben A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Taldone T; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Gandu S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Xu C; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Sharma S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Buddaseth S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Yan P; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Chan LYL; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Gokce A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Rajasekhar VK; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Shrestha L; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Panchal P; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Almodovar J; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Digwal CS; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Rodina A; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Merugu S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Pillarsetty N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Miclea V; Faculty of Automation and Computer Science, Technical University of Cluj-Napoca, Cluj-Napoca, CJ, 400114, Romania., Peter RI; Faculty of Automation and Computer Science, Technical University of Cluj-Napoca, Cluj-Napoca, CJ, 400114, Romania., Wang W; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Ginsberg SD; Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, 10962, USA.; Departments of Psychiatry, Neuroscience & Physiology, and the NYU Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, 10016, USA., Tang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Mattar M; Antitumour Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., de Stanchina E; Antitumour Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Yu KH; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Lowery M; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Grbovic-Huezo O; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., O'Reilly EM; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Janjigian Y; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, 10065, USA., Healey JH; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Jarnagin WR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Allen PJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, 27710, USA., Sander C; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA., Erdjument-Bromage H; Department of Cell Biology, New York University Grossman School of Medicine, New York, NY, 10016, USA.; Kimmel Center for Biology and Medicine at the Skirball Institute, NYU School of Medicine, New York, NY, 10016, USA., Neubert TA; Department of Cell Biology, New York University Grossman School of Medicine, New York, NY, 10016, USA.; Kimmel Center for Biology and Medicine at the Skirball Institute, NYU School of Medicine, New York, NY, 10016, USA., Leach SD; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Lebanon, NH, 03766, USA., Chiosis G; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. chiosisg@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, 10065, USA. chiosisg@mskcc.org.
Publikováno v:
Communications biology [Commun Biol] 2021 Nov 25; Vol. 4 (1), pp. 1333. Date of Electronic Publication: 2021 Nov 25.
Autor:
Zhao Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA., Murciano-Goroff YR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xue JY; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA.; Weill Cornell-Rockefeller-Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA., Ang A; Amgen, Thousand Oaks, CA, USA., Lucas J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA., Mai TT; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA., Da Cruz Paula AF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saiki AY; Amgen, Thousand Oaks, CA, USA., Mohn D; Amgen, Thousand Oaks, CA, USA., Achanta P; Amgen, Thousand Oaks, CA, USA., Sisk AE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arora KS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roy RS; Weill Cornell-Rockefeller-Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA., Kim D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA., Li C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA., Lim LP; Resolution Bioscience, Kirkland, WA, USA., Li M; Resolution Bioscience, Kirkland, WA, USA., Bahr A; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Loomis BR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berger M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Riely G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lipford JR; Amgen, Thousand Oaks, CA, USA., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lito P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer, New York, NY, USA. litop@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. litop@mskcc.org.; Weill Cornell-Rockefeller-Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA. litop@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. litop@mskcc.org.
Publikováno v:
Nature [Nature] 2021 Nov; Vol. 599 (7886), pp. 679-683. Date of Electronic Publication: 2021 Nov 10.
Autor:
Yang Y; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York., McCloskey JE; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York., Yang H; AffyImmune Therapeutics, Inc., Natick, Massachusetts., Puc J; AffyImmune Therapeutics, Inc., Natick, Massachusetts., Alcaina Y; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York., Vedvyas Y; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York., Gomez Gallegos AA; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.; Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Ciudad de México, México., Ortiz-Sánchez E; Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Ciudad de México, México., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., Min IM; Department of Surgery, Weill Cornell Medicine, New York, New York., von Hofe E; AffyImmune Therapeutics, Inc., Natick, Massachusetts., Jin MM; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York. moj2005@med.cornell.edu.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2021 Oct; Vol. 9 (10), pp. 1158-1174. Date of Electronic Publication: 2021 Aug 02.
ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.
Autor:
Portelinha A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thompson S; Asana BioSciences, Lawrenceville, NJ, USA., Smith RA; Asana BioSciences, Lawrenceville, NJ, USA., Da Silva Ferreira M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Asgari Z; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knezevic A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Seshan V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gupta S; Asana BioSciences, Lawrenceville, NJ, USA., Denis L; Asana BioSciences, Lawrenceville, NJ, USA., Younes A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reddy S; Asana BioSciences, Lawrenceville, NJ, USA.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2021 Jul 21; Vol. 2 (7), pp. 100350. Date of Electronic Publication: 2021 Jul 21 (Print Publication: 2021).